indapamide has been researched along with Kidney Diseases in 15 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The fixed low-dose combination of the ACE inhibitor perindopril and the non-thiazide diuretic indapamide has been evaluated in the management of patients with mild to moderate hypertension." | 8.81 | Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension. ( Cheer, SM; Goa, KL; Matheson, AJ, 2001) |
| "In hypertensive patients with Type 2 diabetes, a greater reduction of urinary albumin excretion can be obtained with the perindopril/indapamide association compared with an angiotensin-converting enzyme inhibitor administered as monotherapy." | 5.33 | What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension? ( Waeber, B, 2005) |
| "the Hypertension in the Very Elderly Trial (HYVET) was a randomised placebo-controlled trial of indapamide slow release 1." | 5.17 | Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial. ( Beckett, N; Bulpitt, C; Burch, L; Fagard, R; Fletcher, A; Li, M; Narkiewicz, K; Nitsch, D; Peters, R; Poulter, R; Wang, N, 2013) |
| "The fixed low-dose combination of the ACE inhibitor perindopril and the non-thiazide diuretic indapamide has been evaluated in the management of patients with mild to moderate hypertension." | 4.81 | Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension. ( Cheer, SM; Goa, KL; Matheson, AJ, 2001) |
| "Indapamide is a new antihypertensive diuretic agent indicated for the treatment of hypertension and edema." | 3.66 | Pharmacokinetics and clinical pharmacology of indapamide. ( Caruso, FS; Szabadi, RR; Vukovich, RA, 1983) |
| "In hypertensive patients with Type 2 diabetes, a greater reduction of urinary albumin excretion can be obtained with the perindopril/indapamide association compared with an angiotensin-converting enzyme inhibitor administered as monotherapy." | 1.33 | What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension? ( Waeber, B, 2005) |
| "Indapamide serum binding was increased in patients with inflammatory syndrome (82." | 1.27 | Serum binding of indapamide in health and disease: primary role of alpha 1-acid glycoprotein. ( Coulomb, B; d'Athis, P; Morin, D; Tillement, JP; Urien, S, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Knudsen, ST | 1 |
| Cooper, ME | 1 |
| Mohammedi, K | 1 |
| Chalmers, J | 1 |
| Herrington, W | 1 |
| Li, Q | 1 |
| Mancia, G | 1 |
| Marre, M | 1 |
| Poulter, N | 1 |
| Rodgers, A | 1 |
| Williams, B | 1 |
| Perkovic, V | 1 |
| Coresh, J | 1 |
| Woodward, M | 1 |
| Mourad, JJ | 1 |
| Le Jeune, S | 1 |
| Peters, R | 1 |
| Beckett, N | 1 |
| Poulter, R | 1 |
| Burch, L | 1 |
| Narkiewicz, K | 1 |
| Fagard, R | 1 |
| Nitsch, D | 1 |
| Wang, N | 1 |
| Li, M | 1 |
| Fletcher, A | 1 |
| Bulpitt, C | 1 |
| Fournier, A | 1 |
| Godefroy, O | 1 |
| Oprisiu, R | 1 |
| Slama, M | 1 |
| Andrejak, M | 1 |
| Mogensen, CE | 1 |
| Waeber, B | 1 |
| Caruso, FS | 1 |
| Szabadi, RR | 1 |
| Vukovich, RA | 1 |
| Schiffl, H | 1 |
| Weidmann, P | 1 |
| Meier, A | 1 |
| Ziegler, WH | 1 |
| Brennan, L | 1 |
| Wu, MJ | 1 |
| Laquer, UJ | 1 |
| Uehara, Y | 1 |
| Kawabata, Y | 1 |
| Shirahase, H | 1 |
| Wada, K | 1 |
| Hashizume, Y | 1 |
| Morishita, S | 1 |
| Numabe, A | 1 |
| Iwai, J | 1 |
| Matheson, AJ | 1 |
| Cheer, SM | 1 |
| Goa, KL | 1 |
| Lee, M | 1 |
| Sharifi, R | 1 |
| Urien, S | 1 |
| Morin, D | 1 |
| d'Athis, P | 1 |
| Coulomb, B | 1 |
| Tillement, JP | 1 |
| Rizzi, R | 1 |
| Micoli, A | 1 |
| Giaculli, G | 1 |
| Lella, A | 1 |
| Mariella, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Hypertension in the Very Elderly Trial (HYVET)[NCT00122811] | Phase 4 | 4,000 participants (Anticipated) | Interventional | 2000-11-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for indapamide and Kidney Diseases
| Article | Year |
|---|---|
Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypoglycemic Agents; Indap | 2020 |
Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Cytoprotection; Dose-Response Relationship, Drug; Drug Comb | 2009 |
Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
Topics: Adult; Age Factors; Aged; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; | 2001 |
2 trials available for indapamide and Kidney Diseases
| Article | Year |
|---|---|
Associations between body mass index and the risk of renal events in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Blood Glucose; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Drug Combi | 2018 |
Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.
Topics: Age Factors; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Ag | 2013 |
10 other studies available for indapamide and Kidney Diseases
| Article | Year |
|---|---|
Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; | 2003 |
[Vascular impact of anti-hypertensive treatment and renal protection].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Double-Bl | 2005 |
What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, T | 2005 |
Pharmacokinetics and clinical pharmacology of indapamide.
Topics: Animals; Calcium; Cats; Chemical Phenomena; Chemistry; Diuretics; Dose-Response Relationship, Drug; | 1983 |
Relationship between plasma catecholamines and urinary catecholamine excretion rates in normal subjects and certain diseased states.
Topics: Adult; Blood Pressure; Chlorthalidone; Creatinine; Diabetes Mellitus; Electrolytes; Epinephrine; Fem | 1981 |
A multicenter study of indapamide in hypertensive patients with impaired renal function.
Topics: Adult; Aged; Blood Pressure; Body Weight; Creatinine; Diuretics; Female; Humans; Hypertension; Indap | 1982 |
Oxygen radical scavengers and renal protection by indapamide diuretic in salt-induced hypertension of Dahl strain rats.
Topics: Animals; Antioxidants; Free Radical Scavengers; Free Radicals; Glomerular Filtration Rate; Hypertens | 1993 |
Alternative agents for hypercalciuria.
Topics: Calcium; Diuretics; Humans; Indapamide; Kidney Diseases | 1989 |
Serum binding of indapamide in health and disease: primary role of alpha 1-acid glycoprotein.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Diuretics; Fatty Acids, Nonesterified; Female; Hu | 1988 |
[Hypokalemic myopathy during prolonged anti-hypertensive therapy with indapamide].
Topics: Aged; Diuretics; Female; Heart Diseases; Humans; Hypokalemia; Indapamide; Kidney Diseases; Muscle Hy | 1985 |